References
- Advisory Council on the Misuse of Drugs (ACMD). (2010a). Consideration of the naphthylpyrovalerone analogues and related compounds. Available at: www.homeoffice.gov.uk/agencies-public-bodies/acmd. Accessed on November 26, 2011.
- Advisory Council on the Misuse of Drugs (ACMD). (2010b). Explanatory Memorandum to The Misuse of Drugs (Designation) (Amendment No. 2) (England, Wales and Scotland) No. 1800 and The Misuse of Drugs (Amendment No. 2) (England, Wales and Scotland) Regulations 2010. No. 1799. Available at: www.homeoffice.gov.uk/agencies-public-bodies/acmd. Accessed on November 26, 2011.
- The Ana Liffey Drug Project. (2011). Naphyrone synthesis. Available at: www.drugs.ie/pdfs/2010/Naphyrone_Synthesis.pdf. Accessed on September 21, 2011.
- B2BFreeZone. (2011). Naphyrone buyers—importers and purchasers from USA, UK, and Australia. Available at: www.b2bfreezone.com/buyers/naphyrone.htm. Accessed on September 21, 2011.
- Bluelight. (2011). Psychedelic drugs index: beginners FAQ. Available at: www.bluelight.ru/vb/showthread. Accessed on September 21, 2011.
- Brandt, S. D., Freeman, S., Sumnall, H. R., Measham, F., Cole, J. (2011). Analysis of NRG ‘legal highs’ in the UK: identification and formation of novel cathinones. Drug Test Anal 3:569–575.
- Brandt, S. D., Sumnall, H. R., Measham, F., Cole, J. (2010a). Second generation mephedrone. The confusing case of NRG-1. BMJ 341:c3564.
- Brandt, S. D., Sumnall, H. R., Measham, F., Cole, J. (2010c). Analyses of second-generation ‘legal highs’ in the UK: initial findings. Drug Test Anal 2:377–382.
- Brandt, S. D., Wootton, R. C. R., De Paoli, G., Freeman, S. (2010b). The naphyrone story: the alpha or beta-naphthyl isomer? Drug Test Anal 2:496–502.
- De Paoli, G., Maskell, P. D., Pounder, D. J. (2011). Naphyrone: analytical profile of the new “legal high” substitute for mephedrone. J Forensic Leg Med 18:93.
- Deniker, P., Lôo, H., Cuche, H., Roux, J. M. (1975). Abuse of pyrovalerone by drug addicts. Ann Med Psychol 2:745–748.
- Drugs Forum. (2011). Available at: www.drugs-forum.com/forum/showthread. Accessed on September 21, 2011.
- Eastwood, N., Harris, G. (2010). Legal eye. Drugs Alcohol Today 10:7–9.
- European Monitoring Center for Drugs and Drug Addiction (EMCDDA). (2009). EMCDDA–Europol Annual Report on the implementation of Council Decision 2005/387/JHA in accordance with Article 10 of Council Decision 2005/387/JHA on information exchange. Available at: www.emcdda.europa.eu. Accessed on: November 26, 2011.
- Findit Blog. (2011). Available at: www.findit.gr/area/-7/posts/1/15/35876.html. Accessed on September 21, 2011.
- Gardos, G., Cole, J. O. (1971). Evaluation of pyrovalerone in chronically fatigued volunteers. Curr Ther Res Clin Exp 13:631–635.
- Heffe, W. (1964). Die Stevens-umlagerung von allyl-phenacyl-ammoniumsalzen (The Stevens rearrangement of allyl-phenacyl-ammonium salts). Helv Chim Acta 47:1289–1292.
- Howell, L. L., Kimmel, H. L. (2008). Monoamine transporters and psychostimulant addiction. Biochem. Pharmacol 75:196–217.
- Koob, G. F., Volkow, N. D. (2010). Neurocircuitry of addiction. Europsychopharmacology 35:217–238.
- Melnick, R. L. (2002). Carcinogenicity and mechanistic insights on the behavior of epoxides and epoxide-forming chemicals. Ann N Y Acad Sci 982:177–189.
- Meltzer, P. C., Butler, D., Deschamps, J. R., Madras, B. K. (2006). 1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors. J Med Chem 49:1420–1432.
- Newcombe, R. (2009). The use of mephedrone (M-cat, Meow) in Middlesbrough. Manchester UK: Lifeline Publications and Research.
- Schifano, F., Albanese, A., Fergus, S., Stair, J. L., Deluca, P., Corazza, O., et al. (2011). Mephedrone (4-methylmethcathinone; ‘meow meow’): chemical, pharmacological and clinical issues. Psychopharmacology (Berl) 214:593–602.
- Smith, C., Cardile, A. P., Miller, M. (2011). Bath salts as a “legal high” Am J Med 124:e7–e8.
- The Misuse of Drugs (Amendment No. 2) (England, Wales, and Scotland). (2010). Regulations 2010. No. 1799. Available at: legislation.gov.uk. Accessed on November 26, 2011.
- Travis, A. (2010, April 1): NRG-1 may be next legal high to face ban by ministers. The Guardian (newspaper). Available at: www.guardian.co.uk. Accessed on November 26, 2011.
- Turillazzi, E., Riezzo, I., Neri, M., Bello, S., Fineschi, V. (2010). MDMA toxicity and pathological consequences: a review about experimental data and autopsy findings. Curr Pharm Biotechnol 11:500–509.
- United States Naphyrone Directory. (2011). Available at: us.countrysearch.ec21.com/naphyrone.html. Accessed on September 21, 2011.
- Vardakou, I., Pistos, C., Spiliopoulou, Ch. (2010). Spice drugs as a new trend: mode of action, identification and legislation. Toxicol Lett 197:157–162.
- Vardakou, I., Pistos, C., Spiliopoulou, Ch. (2011). Drugs for youth via Internet and the example of mephedrone. Toxicol Lett 201:191–195.
- Wheeler, V. (2010, March 31). NRG-1 is 25p a hit and will kill many more than meow. The Sun (newspaper). Available at: www.thesun.co.uk. Accessed on November 26, 2011.